Membranoproliferative glomerulonephritis type I, mixed cryoglobulinemia and lymphoma in the absence of hepatitis C infection

American Journal of Nephrology

Volumn 19, Issue 5, 1999, Pages 599-604

  Rosas, Sylvia E ^a   Tomaszewski, John E ^a   Feldman, Harold I ^a   Foster, Mary H ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

B cell proliferation; Cryoglobulinemia; Lymphoma; Membranoproliferative glomerulonephritis

Indexed keywords

AUTOANTIBODY; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GLUCOCORTICOID; KIDNEY ANTIBODY; METHYLPREDNISOLONE; PREDNISOLONE; VINCRISTINE;

ADULT; ARTICLE; B CELL LYMPHOMA; CASE REPORT; CRYOGLOBULINEMIA; GENETIC SUSCEPTIBILITY; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOSTIMULATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PRIORITY JOURNAL; UROGENITAL TRACT INFLAMMATION;

EID: 0032754321     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013527     Document Type: Article

References (36)

1. Agnello V, Chung R, Kaplan L: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-1495.
2. Johnson R, Gretch D, Yamabe H, et al: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993;328:465-470.
3. D'Amico G, Fornasieri A: Cryoglobulinemic glomerulonephritis: A membranoproliferative glomerulonephritis induced by hepatitis C virus. Am J Kidney Dis 1995;25:361-369.
4. Pozzato G, Mazzaro C, Crovatto M, et al: Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994;84:3047-3053.
5. Rennke HG: Secondary membranoproliferative glomerulonephritis. Kidney Int 1995;47: 643-656.
6. Monti G, Galli M, Invernizzi F, et al: Cryoglobulinaemias: A multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. Q J Med 1995;88:115-126.
7. Moulin B, Ronco PM, Mougenot B, François A, Fillastre J-P, Mignon F: Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas. Kidney Int 1992;42:127-135.
8. Zlotnick A, Rosenmann E: Renal pathologic findings associated with monoclonal gammopathies. Arch Intern Med 1975;135:40-45.
9. Dolcher M, Marchini B, Sabbatini A, et al: Autoantibodies from mixed cryoglobulinaemia patients bind glomerular antigens. Clin Exp Immunol 1994;96:317-322.
10. Fornasieri A, Li M, Armelloni S, et al: Glomerulonephritis induced by human IgMk-IgG cryoglobulins in mice. Lab Invest 1993;69: 531-540.
11. Fornasieri A, Armelloni S, Bernasconi P, et al: High binding of immunoglobulin Mk rheumatoid factor from type II cryoglobulins to cellular fibronectin: A mechanism for induction of in situ immune complex glomerulonephritis? Am J Kidney Dis 1996;27:476-483.
12. McMurray R, Elbourne K: Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997;26:689-701.
13. Fulpius T, Berney T, Lemoine R, et al: Glomerulopathy induced by IgG3 anti-trinitrophenyl monoclonal cryoglobulins derived from non-autoimmine mice. Kidney Int 1994;45: 962-971.
14. Reininger L, Berney T, Shibata T. Spertini F, Merino R, Izui S: Cryoglobulinernia induced by a murine IgG3 rheumatoid factor: Skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms. Proc Natl Acad Sci USA 1990;87:10038-10042.
15. Lemoine R, Berney T, Shibata T, et al: Induction of 'wire-loop' lesions by murine monoclonal IgG3 cryoglobulins. Kidney Int 1992;41:65-72.
16. Izui S, Berney T, Shibata T, Fulpius T: IgG3 cryoglobulins in autoimmune MRL-lpr/lpr mice: Immunopathogenesis, therapeutic approaches and relevance to similar human diseases. Ann Rheum Dis 1993;52(suppl 1):48-54.
17. Johnson R, Gretch D, Couser W, et al: Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int 1994;46:1700-1704.
18. Cacoub P, Fabiani FL, Musset L, et al: Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994;96:124-132.
19. Casato M, Pucillo LP, Lagana B, Taliani G, Goffredo F, Bonomo L: Cryoglobulinaemia and hepatitis C virus. Lancet 1991;337:1047-1050.
20. Ferri C, Greco F, Longombardo G, et al: Anti-bodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 1991;34:1606-1610.
21. Misiani R, Bellavita P, Fenili D, et al: Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Int Med 1992; 117:573-577.
22. Rostoker G, Pawlotsky JM, Bastie A, Weil B, Dhumeaux D: Type I membranoproliferative glomerulonephritis and HCV infection. Nephrol Dial Transplant 1996;11(suppl 4):22-24.
23. Satoh M, Kumar A, Kanwar Y, Reeves W: Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/ mice treated with pristane. Proc Natl Acad Sci USA 1995;92:10934-10938.
24. Satoh M, Hamilton K, Ajmani A, et al: Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. J Immunol 1996;157: 3200-3206.
25. Potter M, Wiener F: Plasmacytomagenesis in mice: Model of neoplastic development dependent upon chromosomal translocations. Carcinogenesis 1992;13:1681-1697.
26. Rault R, Holley JL, Banner BF, El-Shahawy M: Glomerulonephritis and non-Hodgkin's lymphoma: A report of two cases and review of the literature. Am J Kidney Dis 1992;20:84-89.
27. Zahner J, Gerharz C-D, Bach D, et al: Association of primary renal non-Hodgkin's lymphoma with mesangioproliferative glomerulonephritis. Am J Hematol 1996;53:126-132.
28. D'Amico G, Colasanti G, Ferrario F, Sinico RA: Renal involvement in essential mixed cryoglobulinemia. Kidney Int 1989;35:1004-1014.
29. Misiani R, Bellavita P: Mixed cryoglobulinemia. A guide to drug treatment. Clin Immunother 1996;5:115-121.
30. De Vecchi A, Montagnino G, Pozzi C, Tarantino A, Locatelli F, Ponticelli C: Intravenous methylprednisolone pulse therapy in essential mixed cryoglobulinemia nephropathy. Clin Nephrol 1983;19:221-227.
31. Lee T, Miller W, Curd J, Piro L, Saven A: Prolonged, complete remission after 2-chlorode-oxyadenosine therapy in a patient with refractory essential mixed cryoglobulinemia. Mayo Clin Proc 1996;71:966-968.
32. Spertini F, Donati Y, Welle I, Izui S, Lambert P: Prevention of murine cryoglobulinemia and associated pathology by monoclonal anti-idiotypic antibody. J Immunol 1989;143:2508-2513.
33. White C, Halpern S, Parker B, et al: Radioimmunotherapy of relapsed B-cell lymphoma with yttrium 90 anti-idiotype monoclonal antibodies. Blood 1996;87:3640-3649.
34. Stehman-Breen C, Willson R, Alpers C, Gretch D, Johnson R: Hepatitis C virus-associated glomerulonephritis. Curr Opin Nephrol Hypertens 1995;4:287-294.
35. Mazzaro C, Franzin F, Tulissi P, et al: Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to α-interferon therapy. Cancer 1996;77:2604-2613.
36. Tarantino A, Campise M, Banfi G, et al: Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 1995;47:618-623.